Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis
PROHIP
7 other identifiers
interventional
109
1 country
4
Brief Summary
Hip osteoarthritis is associated with joint pain, physical disability, decreased muscle strength and poor health status, and the most common cause for total hip arthroplasty. No studies have investigated the effect of total hip arthroplasty compared to non-surgical treatment in patients with end-stage hip osteoarthritis. This comparison is of upmost importance as it is unknown whether non-surgical treatment may be used as an alternate to surgery. The purpose of this study is to investigate whether total hip arthroplasty followed by standard care is superior to progressive resistance training for improving hip function and pain in patients with end-stage hip osteoarthritis. The hypothesis is that patients treated with total hip arthroplasty will improve more than patients treated with progressive resistance training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedStudy Start
First participant enrolled
September 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMay 18, 2025
May 1, 2025
2.7 years
August 12, 2019
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the Oxford Hip Score (OHS) from baseline to 6 months
The OHS is a 12-item patient-reported outcome measure designed to assess hip function and pain within the last four weeks among patients suffering from hip osteoarthritis in one score. The total score ranges from 0 to 48, with higher scores indicating better disease status.
6 months
Secondary Outcomes (9)
Change in the Hip disability and Osteoarthritis Outcome Score (HOOS) pain subscale from baseline to 6 months
6 months
Change in the HOOS symptoms subscale from baseline to 6 months
6 months
Change in the HOOS activities of daily living (ADL) function subscale from baseline to 6 months
6 months
Change in the HOOS quality-of-life subscale from baseline to 6 months
6 months
Change in the HOOS sports and recreation subscale from baseline to 6 months
6 months.
- +4 more secondary outcomes
Other Outcomes (14)
Change in hip pain intensity on a 101-point Visual Analogue Scale (VAS) from baseline to 6 months
6 months
Change in EuroQol Group 5-dimension 5-level (EQ-5D-5L) from baseline to 6 months
6 months
Change in number of patients using pain medication related to the hip from baseline to 6 months
6 months
- +11 more other outcomes
Study Arms (2)
Total Hip Arthroplasty
ACTIVE COMPARATORA standard fast-track multimodal surgical program comprising patient information, optimised pain management, and early mobilisation. Total hip arthroplasty (THA) will be performed by experienced orthopaedic surgeons in accordance with the standard posterior surgical approach. Patients will receive standard postoperative rehabilitation consisting of either a standard leaflet with a hospital-specific home-based exercise program aimed at increasing hip muscle strength and range of motion or, if considered necessary, a referral to supervised hip-specific exercise therapy delivered at private physiotherapist clinics or municipal rehabilitation. Furthermore, postsurgical procedures will follow hospital-specific procedures ranging from no postsurgical control to postsurgical assessment of the hip and rehabilitation at the physiotherapy department (after six-weeks).
Progressive Resistance Training
ACTIVE COMPARATORA 12-week supervised explosive-type progressive resistance training (PRT) program with two training sessions a week. All training sessions will be conducted in municipal rehabilitation centres with one-to-one supervision and ≥48 hours of rest in between sessions. The standardised PRT program will consist of warm-up on a stationary bicycle (10 min) followed by four lower extremity exercises (50 min). Exercises will be performed unilaterally with as full range of motion as possible in sets of three separated by 60 sec of rest in the following order: leg press, hip extension, hip flexion, and hip abduction. Patients will be instructed to complete the concentric phase of each repetition "as fast as possible", maintain full extension for 1 sec, and perform the eccentric phase in 2-3 sec. Hip-related pain up to 5 rated on a Numerical Rating Scale (0-10) is considered acceptable during exercises. After the 12-weeks, patients will be offered three-months of optional unsupervised PRT.
Interventions
Total hip arthroplasty following standard procedures.
Progressive resistance training based on available evidence on patients with hip osteoarthritis and designed in accordance with the "American College of Sports Medicine" (ACSM) recommendations for progression models in resistance training aiming at inducing muscle hypertrophy and increasing muscle strength and power.
Eligibility Criteria
You may qualify if:
- Adults aged ≥50 years
- Clinical history and symptoms consistent with primary hip osteoarthritis (including hip osteoarthritis due to mild hip dysplasia that may be treated with standard components) and radiographic verified hip osteoarthritis defined as joint space narrowing \<2 mm
- Considered eligible for total hip arthroplasty by an orthopaedic surgeon (i.e. duration of symptoms \>3 months, hip related pain, functional impairment or decreased range of motion (ROM), and attempted treatment with analgesics)
You may not qualify if:
- Severe walking deficits (dependency of two crutches or walker)
- Body Mass Index \>35 kg/m2
- Planned other lower extremity surgery within six months
- Cancer diagnosis and receiving chemo-, immuno- or radiotherapy
- Neurological diseases (e.g. previous stroke, multiple sclerosis, Parkinson's, Alzheimer's).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vejle Hospitallead
- Odense University Hospitalcollaborator
- Naestved Hospitalcollaborator
- Aarhus University Hospitalcollaborator
- The Danish Rheumatism Associationcollaborator
- Region of Southern Denmarkcollaborator
- Association of Danish Physiotherapistscollaborator
- The Research Council at Naestved-Slagelse-Ringsted Hospitalscollaborator
Study Sites (4)
Department of Orthopaedic Surgery, Aarhus University Hospital (AUH)
Aarhus, 8200, Denmark
Department of Orthopaedic Surgery, Naestved Hospital
Næstved, 4700, Denmark
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital (OUH)
Odense, 5000, Denmark
Depatment of Orthopaedic Surgery, Vejle Hospital
Vejle, 7100, Denmark
Related Publications (4)
Bryld ES, Christiansen L, Ingwersen KG, Overgaard S, Mikkelsen LR, Mechlenburg I, Frydendal T. Training load and pain response during progressive resistance training in patients with hip osteoarthritis in the PROHIP trial. Osteoarthr Cartil Open. 2025 Oct 4;7(4):100690. doi: 10.1016/j.ocarto.2025.100690. eCollection 2025 Dec.
PMID: 41141645DERIVEDFrydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Varnum C, Graversen AE, Kjaersgaard-Andersen P, Revald PH, Hofbauer C, Bieder MJ, Qassim H, Munir MS, Jakobsen SS, Nielsen SM, Ingwersen KG, Overgaard S. Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis. N Engl J Med. 2024 Oct 31;391(17):1610-1620. doi: 10.1056/NEJMoa2400141.
PMID: 39476341DERIVEDFrydendal T, Thomsen KS, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG, Myburgh C. Patient and public involvement to inform the protocol of a clinical trial comparing total hip arthroplasty with exercise: an exploratory qualitative case study. BMJ Open. 2023 Apr 24;13(4):e070866. doi: 10.1136/bmjopen-2022-070866.
PMID: 37094895DERIVEDFrydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG. Total hip arthroplasty versus progressive resistance training in patients with severe hip osteoarthritis: protocol for a multicentre, parallel-group, randomised controlled superiority trial. BMJ Open. 2021 Oct 22;11(10):e051392. doi: 10.1136/bmjopen-2021-051392.
PMID: 34686555DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Frydendal, PT, MSc
Vejle Hospital and University of Southern Denmark
- STUDY DIRECTOR
Søren Overgaard, Prof., MD
Odense University Hospital and University of Southern Denmark
- STUDY CHAIR
Inger Mechlenburg, Prof., DMSc
Aarhus University Hospital and Aarhus University
- STUDY CHAIR
Kim Gordon Ingwersen, PT, PhD
Vejle Hospital and University of Southern Denmark
- STUDY CHAIR
Lone Ramer Mikkelsen, PT, PhD
Silkeborg Regional Hospital
- STUDY CHAIR
Robin Christensen, Prof., PhD
The Parker Institute and Odense University Hospital
- STUDY CHAIR
Claus Varnum, PhD, MD
Vejle Hospital
- STUDY CHAIR
Henrik Morville Schrøder, PhD, MD
Naestved Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2019
First Posted
August 28, 2019
Study Start
September 2, 2019
Primary Completion
May 5, 2022
Study Completion (Estimated)
June 1, 2026
Last Updated
May 18, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be available after publication of the trial.
- Access Criteria
- Data access will be reviewed by the author group. Requestors will be required to sign a Data Access Agreement.
Anonymised patient-level data for the primary and all secondary outcome measures will be made available if required by the scientific journal, in which the results of the trial are published.